explore -WSS

explore

author：hotspot 2025-09-27 23:03:16 - browse：6

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

focus

leisure time

WSS

Canadians with cystic fibrosis outlive Americans by a decade

Teach medical students about patients with intellectual disabilities

After sickle

CMS should re

After sickle

Use doctors trained outside the U.S. to ease the physician shortage

focus

explore

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

What affirmative action's end means to a medical student

In age of alternative facts, a scholarly course on calling out crap

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

What does generative AI mean for health care? We asked experts

Lupron, used to halt puberty in children, may cause lasting health problems

Alkermes shareholders re

Chemotherapy shortages won’t get better under Biden’s latest plan

The cancer drug shortage isn’t new — and neither are the solutions

Fatty liver disease was alleviated by Lilly’s ‘triple

focus

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

AstraZeneca lung cancer study comes in below expectations

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Spinal cord stimulation reduces pain in amputees, study finds

Teach medical students about patients with intellectual disabilities

What PEPFAR has meant on the ground in Ukraine

focus

focus

leisure time

explore